MAGNESIUM STEARATE

Molecular Excipient

SMILES

Mwt.	LogP	HBD	HBA	PSA	RB	CSP3
283.0	5.0	0	2	40.0	16	0.94

CAS

557040

UNII

70097M6I30

SYNONYMS

ZINC ID(s)

ZINC4978673

Availability

Present in 82 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).

Name	Description	Classification
PPARD	Peroxisome proliferator-activated receptor delta	Unclassified / Unclassified
PPARA	Peroxisome proliferator-activated receptor alpha	Transcription Factor / Nr

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Browse on ZINC

Functions of Magnesium Stearate

Af - Antifoaming (or defoaming) agent
Misc - Miscellaneous

Regulatory Status of Magnesium Stearate

Reg - Food additives for which a petition has been filed and a regulation issued.

Dosages

Route	Formulation	Per Unit Dose
Buccal	Tablet	4MG
Buccal	Tablet, Extended Release	0.58MG
Buccal/sublingual	Tablet	17.5MG
Im - Iv	Injection	0.13%
Implantation	Drug Delivery System	0.02MG
Implantation	Implant	0.1MG
Intravitreal	Drug Delivery System	0.02MG
Intravitreal	Implant	0.005MG
Oral	Capsule	256.4MG
Oral	Capsule (Immed./comp. Release)	2.5MG
Oral	Capsule (Immed./comp. Release), Hard Gelatin	10MG
Oral	Capsule, Coated Pellets	0.15MG
Oral	Capsule, Coated, Soft Gelatin	3MG
Oral	Capsule, Delayed Action	10.69MG
Oral	Capsule, Delayed Action, Enteric Coated
Oral	Capsule, Delayed Action, Enteric Coated, Hard Gelatin	6.2MG
Oral	Capsule, Enteric Coated Pellets	34.87MG
Oral	Capsule, Extended Release	9.16MG
Oral	Capsule, Gelatin Coated	1.5MG
Oral	Capsule, Hard Gelatin	79.4MG
Oral	Capsule, Soft Gelatin	9MG
Oral	Capsule, Sustained Action	100MG
Oral	Concentrate
Oral	Dispersible Tablet	0.32MG
Oral	Drops
Oral	Granule	4MG
Oral	Granule, For Oral Suspension	7MG
Oral	Pellet	2.6MG
Oral	Powder	0.84%
Oral	Powder, For Inhalation	0.01%
Oral	Powder, For Oral Suspension	0.3%
Oral	Powder, For Suspension	0.65%
Oral	Suspension	1.15%
Oral	Suspension, Sustained Action	2.7%
Oral	Tablet	2MG
Oral	Tablet (Immed./comp. Release), Coated	6.4MG
Oral	Tablet (Immed./comp. Release), Film Coated	20.5MG
Oral	Tablet (Immed./comp. Release), Uncoated, Chewable	50MG
Oral	Tablet, Chewable	5.5MG
Oral	Tablet, Coated	40MG
Oral	Tablet, Controlled Release	12.4MG
Oral	Tablet, Delayed Action	14MG
Oral	Tablet, Delayed Action, Enteric Coated	53.8MG
Oral	Tablet, Delayed Release	2.1MG
Oral	Tablet, Delayed Release	5MG
Oral	Tablet, Dispersible	4.5MG
Oral	Tablet, Enteric Coated Particles	7MG
Oral	Tablet, Extended Release	26.66MG
Oral	Tablet, Film Coated	28.31MG
Oral	Tablet, Film Coated, Extended Release	10.02MG
Oral	Tablet, For Suspension	12.5MG
Oral	Tablet, Multilayer, Coated	3MG
Oral	Tablet, Multilayer, Extended Release	1.2MG
Oral	Tablet, Orally Disintegrating	71.43MG
Oral	Tablet, Orally Disintegrating, Delayed Release	6MG
Oral	Tablet, Repeat Action	1.2MG
Oral	Tablet, Sustained Action	150MG
Oral	Tablet, Sustained Action, Coated	10MG
Oral	Tablet, Sustained Action, Film Coated	15.8MG
Oral	Tablet, Sustained Release, Film Coated	4.28MG
Oral	Tablet, Uncoated, Lozenge	15MG
Oral	Tablet, Uncoated, Troche	20MG
Oral	Troche	21MG
Oral	Wafer	15MG
Oral-20	Tablet	1.5MG
Oral-21	Tablet	1.5MG
Oral-21	Tablet, Coated	0.88MG
Oral-28	Tablet	75MG
Oral-28	Tablet, Coated	0.88MG
Oral-28	Tablet, Film Coated	0.35MG
Subcutaneous	Implant	0.5MG
Sublingual	Tablet	6MG
Sublingual	Tablet (Immed./comp. Release), Uncoated, Buccal	3MG
Topical	Emulsion, Cream	0.001%
Transdermal	Patch, Electrically Controlled	9.65MG
Transmucosal	Tablet	1.5MG
Vaginal	Insert	23MG
Vaginal	Tablet	23MG
Vaginal	Tablet, Film Coated	0.4MG

More Information

Usage Over Time

Data provided by OpenFDA